Jump Financial, LLC Aclaris Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.4 $25,226 - $31,533	-22,524 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.36 $22,749 - $30,632	22,524 New	22,524 $24,000
Q1 2022 May 12, 2022	SELL	$9.74 - $17.92 $311,680 - $573,440	-32,000 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$12.27 - $18.49 $392,640 - $591,680	32,000 New	32,000 $465,000
Q3 2021 Nov 12, 2021	SELL	$13.38 - $18.8 $464,807 - $653,093	-34,739 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $593,342 - $1.03 Million	34,739 New	34,739 $609,000
Q1 2021 May 17, 2021	SELL	$5.86 - $27.73 $63,288 - $299,484	-10,800 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.65 - $7.61 $28,620 - $82,188	10,800 New	10,800 $70,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $182M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.